期刊文献+

鼠IL-35真核表达载体的构建及在Hepa1-6细胞中的表达

Construction of the Eukaryotic Expression Vector Containing Mouse Interleukin-35 Gene andExpression in Hepa1-6 Cells
下载PDF
导出
摘要 目的 构建小鼠IL-35的真核表达载体并使其在小鼠肝癌细胞株Hepa1-6中表达.方法 采用PCR方法从含有小鼠IL-35基因的pET-30a-mIL-35中扩增目的 基因片段,将其克隆到真核表达载体pcDNA3.1/V5-HisB中,经菌落PCR、双酶切鉴定及测序正确后,用脂质体转染方法转染到Hepa1-6细胞中,48h后收集细胞,SDS-PAGE和Western Blotting检测目的 蛋白的表达.结果 经双酶切和测序鉴定证实重组表达载体构建成功,转染入Hepa1-6细胞经SDS-PAGE电泳和Western Blotting证明均得到与预期相对分子量大小相符的蛋白条带.结论 成功构建小鼠IL-35真核表达载体并在Hepa1-6细胞中表达,为进一步研究mIL-35的生物学功能提供了条件. Objective To construct eukaryotic expression vector of mouse interleukin-35 gene and observe its expression in mouse hepatoma cells Hepa1-6. Methods The gene containing mouse mIL-35 was amplified by PCR from the pET30a-IL-35 and cloned into the eukaryotic expression vector pcDNA3, 1/V5-HisB. The recombinant plasmid was transfected into Hepal-6 cells by the lipofeetion method. The cells were collected after 48h. The expression of the target molecule was identified with SDS-PAGE and Western Blotting. Results The recombinant expression vector was identified and confirmed by digestion of restriction enzyme and DNA sequencing. SDS-PAGE electrophoresis and Western Blotting were proved to have a size protein bands consistent with the expected molecular weigtht. Conclusion Mouse raiL-35 can expresse in Hepal-6 cells. It provides the conditions for the further study of roIL-35 in tumor cells.
出处 《潍坊医学院学报》 2012年第1期41-43,66,共4页 Acta Academiae Medicinae Weifang
基金 山东省自然基金资助项目(课题编号:ZR2009CM019) 潍坊医学院研究生创新基金(课题编号:YC2008014)
关键词 mIL-35 载体构建 Hepa1-6 roIL-35 Vector Constrution Hepa1-6
  • 相关文献

参考文献6

  • 1Niedbala W,Wei XQ,Cai B. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells[J].European Journal of Immunology,2007,(11):3021-3029.
  • 2Collison LW,Workman CJ,Kuo TT. The inhibitory cytokine IL-35 contributes to regulatory T-cell function[J].Nature,2007,(7169):566-569.
  • 3Huang CH,Loo EX,Kuo IC. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35[J].Journal of Immunology,2011,(01):462-471.
  • 4唐媛媛,鞠吉雨,朱平,王丽娜,林志娟,邸大琳,苗乃法.小鼠IL-35基因的克隆及原核表达[J].潍坊医学院学报,2010,32(5):324-327. 被引量:2
  • 5Kochetkova I,Golden S,Holderness K. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10[J].Journal of Immunology,2010,(12):7144-7153.
  • 6Collison LW,Chaturvedi V,Henderson AL. IL-35-mediated induction of a potent regulatory T cell population[J].Nature Immunology,2010,(12):1093-1101.

二级参考文献7

  • 1Collison LW,Workman CJ,Kuo TT,et al.The inhibitory cytokine IL-35contributes to regulatory T-cell function[J].Nature,2007,450(22):566-569.
  • 2Niedbala W,Wei XQ,Cai B,et al.IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells[J].Eur J Immunol,2007,37(11):3021-3029.
  • 3Devergne O,Hummel M,Koeppen H,et al.A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes[J].J Virol,1996,70(2):1143-1153.
  • 4Seyerl M,Kirchberger S,Majdic O,et al.Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1(CD274) and sialoadhesin(CD169) on DC[J].Eur J Immunol,2010,40(2):321-329.
  • 5Bardel E,Larousserie F,Charlot-Rabiega P,et al.Human CD4+CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35[J].J Immunol,2008,181(10):6898-6905.
  • 6Kochetkova I,Golden S,Holderness K,et al.IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10[J].J Immunol,2010,84(12):7144-7153.
  • 7袁芳,杜小萍(综述),鞠吉雨(审阅).新型抑制性细胞因子IL-35研究进展[J].现代免疫学,2009,29(4):348-351. 被引量:5

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部